Glenmark gets USFDA nod for generic skin ointment
Glenmark Pharmaceuticals has received approval from the US health regulator to market Desonide ointment, used to treat skin problems, in the American market. Glenmark Pharmaceuticals Inc, a... Press Release / Media Release
Sub: Glenmark Pharmaceuticals receives ANDA approval for Desonide Ointment, 0.05% With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Glenmark looks to file up to 25 product applications annually
Glenmark Pharmaceuticals plans to file close to 25 product applications annually over the next five years, the company's chairman has said. The Mumbai-based firm also expects to launch nearly 20... Glenmark awaiting fresh triggers
Large product approvals, deals can drive growth, help pare debt Glenmark gets USFDA approval for Rythmol SR generic version
Glenmark Pharmaceuticals has received final approval from the US health regulator for generic version of Rythmol SR capsules, an anti-arrhythmic medication, which treats illnesses associated with... Press Release / Media Release
Dear Sirs, Sub: Glenmark Pharmaceuticals receives ANDA approval for Propafenone Hydrochloride Extended-Release Capsules USP, 225 mg, 325 mg, and 425 mg With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Submission Of Notice For Attention Of Equity Shareholders Of The Company In Respect Of 39Th Annual General Meeting To Be Held On 29Th September, 2017
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are hereby enclose copies of the notice for the attention of the equity shareholders of the Company in respect of the Notice of 39th Annual General Meeting scheduled to be held on Friday, 29th September, 2017 in the following newspapers: 1. Financial Express in English 2. Loksatta in Marathi Request you to kindly take the same on record. AGM On September 29, 2017
Further to our letter dated 4th August, 2017, enclosed please find herewith the Notice Convening the 39th Annual General Meeting of the Company scheduled to be held on Friday, 29th September, 2017 for your information and record. Glenmark Pharma: Bet on a bounce back
Glenmark Pharmaceuticals (612): The long and medium-term outlook for the pharma major is negative. A crucial support is at 584 and a close below that will trigger a fresh selling. Immediate... Glenmark Pharma gets USFDA nod for generic skin ointment
The ointment is used for treating skin inflamation